Complicated Tuberculosis Meningitis (TBM): A Case Report

  • Parviz Afrough Mail 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
  • Ava Behrouzi 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
  • Morteza Masoumi 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Ira
  • Hasan Ghajavand 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Ira
  • Farzaneh Mohaghegh Dolatabadi Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.
Keywords:
Tuberculosis meningitis, TBM.

Abstract

Background: One of the most serious types of meningitis caused by Mycobacterium tuberculosis (MTB) which involves meningeal layer and is usually associated with high mortality and morbidity. We focused on the significance diagnosis and prompt treatment.Methods: We describe a case of TBM.In a 40-Year-old Asian male. He was no respiratory distress, neck stiffness, constipation, and nausea, but frequent urination. In addition, the patient had a history of drug addiction.Results: His Magnetic Resonance Imaging (MRI) showed hyperintense Lesions. Sputum culture for Mycobacterium tuberculosis (MTB) was found positive and he was given a therapeutic trial of quinolones and Steroids.Conclusion: Observing the principles of biological safety among the personnel of medical centers and screening for TB disease in drug-positive and HIV-positive is essential.

Author Biographies

Parviz Afrough, 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
Department of Mycobacteriology and Pulmonary Research
Ava Behrouzi, 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Iran
Department of Mycobacteriology and Pulmonary Research
Morteza Masoumi, 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Ira
Department of Mycobacteriology and Pulmonary Research
Hasan Ghajavand, 1- Department of Mycobacteriology & Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran 2- Microbiology Research Center (MRC), Pasteur Institute of Iran, Tehran, Ira
Department of Mycobacteriology and Pulmonary Research

References

Reference:

Brennan, P.J (2003).Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis, 83(1): 91-97.

Russell, D.G (2001). Mycobacterium tuberculosis: here today, and here tomorrow. Nature reviews Molecular cell biology, 2(8): 569-574.

Bernaerts, A., et al (2003). Tuberculosis of the central nervous system: overview of neuroradiological findings. European radiology, 13(8): 1876-1890.

Farinha, N., et al (2000). Tuberculosis of the central nervous system in children: a 20-year survey. Journal of infection, 41(1): 61-68.

Katti, M.K (2004). Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Medical Science Monitor, 10(9): 215-229.

Arbeláez, A., et al (2004). Cerebral tuberculosis. In Seminars in roentgenology. Elsevier.

Bathla, G., et al (2011). Manifestations of cerebral tuberculosis. Singapore Medical Journal, 52(2): 124-131.

Organization, W.H., and S.T. Initiative (2010). Treatment of tuberculosis: Guidelines. World Health Organization.

Caminero, J.A., et al (2010). Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis. The Lancet infectious diseases, 10(9): 621-629.

Myers, J.P (2005).New recommendations for the treatment of tuberculosis. Current opinion in infectious diseases, 18(2): 133-140.

Berning, S.E., T.A. Cherry, M.D. Iseman (2001). Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clinical infectious diseases, 32(4): 643-646.

Graham, S.M., et al (2014). Importance of tuberculosis control to address child survival. The Lancet, 383(9928): 1605-1607.

Nyendak, M.R., D.A. Lewinsohn, D.M. Lewinsohn (2009). New diagnostic methods for tuberculosis. Current opinion in infectious diseases, 22(2): 174-177.

Andersen, P., et al (2000). Specific immune-based diagnosis of tuberculosis. The Lancet, 356: 1099-1104.

Katrak, S.M., et al (2000). The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. Journal of the Neurological Sciences, 181(1): 118-126.

Published
2019-09-12
How to Cite
1.
Afrough P, Behrouzi A, Masoumi M, Ghajavand H, Mohaghegh Dolatabadi F. Complicated Tuberculosis Meningitis (TBM): A Case Report. J Med Bacteriol. 8(5-6):64-68.
Section
Case Reports